Related Experiment Video
Updated: Jun 29, 2026

06:52
Behavioral and Locomotor Measurements Using an Open Field Activity Monitoring System for Skeletal Muscle Diseases
Published on: September 29, 2014
Polymyositis in dogs
Journal of the American Veterinary Medical Association
|March 1, 1980
Summary
Canine polymyositis diagnosis involves muscle pain, weakness, and specific tests. Prednisone treatment showed effectiveness in some dogs, though complications like aspiration pneumonia occurred.
Area of Science:
- Veterinary Medicine
- Canine Pathology
- Neuromuscular Diseases
Background:
- Polymyositis is an inflammatory muscle disease affecting dogs.
- Diagnosis can be challenging due to variable clinical signs and laboratory findings.
Purpose of the Study:
- To describe the diagnostic factors, clinical signs, and treatment outcomes in nine dogs diagnosed with polymyositis.
- To evaluate the utility of serum muscle enzyme concentrations and electromyography in diagnosing canine polymyositis.
Main Methods:
- Diagnosis based on clinical signs (muscle pain/weakness), serum muscle enzymes, electromyography, and histopathology.
- Clinical signs, diagnostic test results, and treatment responses were recorded.
- Prednisone was administered at 2.2 mg/kg once daily.
Main Results:
- Nine dogs diagnosed with polymyositis.
- Clinical signs included pain, weakness, stilted gait, and pyrexia.
- Elevated serum muscle enzymes were present in only three dogs, with no clear correlation to disease severity.
- Electromyography showed characteristic changes.
- Histopathology revealed muscle degeneration, inflammation, and regeneration.
- Prednisone was effective in four dogs.
- Complications included aspiration pneumonia secondary to megaesophagus in three dogs.
Conclusions:
- Canine polymyositis diagnosis requires a combination of clinical, electrodiagnostic, and histopathologic findings.
- Serum muscle enzyme levels may not reliably reflect disease severity.
- Prednisone can be an effective treatment, but potential complications should be monitored.
Related Concept Videos
Myasthenia Gravis: Overview and Treatment
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which leads...
Myocarditis I: Introduction
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Myocarditis II: Clinical Features and Diagnostic Tests
Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...
Myocarditis III: Medical Management
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Poliomyelitis
Poliomyelitis is caused by poliovirus, a small, non-enveloped, positive-sense RNA virus of the Picornaviridae family and Enterovirus genus. Transmission occurs primarily via the fecal-oral route, often through ingestion of contaminated water or food. The virus initially replicates in the oropharynx and intestinal mucosa, particularly in lymphoid tissues such as the tonsils, Peyer’s patches, and regional lymph nodes. Primary viremia follows, allowing dissemination throughout the body.In most...
Myasthenia Gravis ll: Pathophysiology
The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...

